Bisacodyl Market 2022-2028

Global Bisacodyl Market Size, Share & Trends Analysis Report by Type ( High Purity and Low Purity), by Application (Constipation and Neurogenic Bowl Dysfunction) Forecast 2022-2028.

The global bisacodyl market is expected to grow at a significant CAGR of 5.9 % during the forecast period of 2022 -2028. Bisacodyl is used on a short-term basis to treat constipation. It is also used to empty the bowels before surgery and certain medical procedures bisacodyl is a class of medications called stimulant laxatives. It works by increasing the activity of the intestines to cause a bowel movement

The increasing incidences of constipation is contributing to the growth of the market. Abbott, one of India's largest healthcare firms, undertook a nationwide Gut Health Survey to analyze the status of constipation patients across the country, as well as the relationship between constipation and comorbidities including diabetes, hypothyroidism, and anorectal illnesses. According to the findings, 22% of the adult Indian population suffers from constipation, with 13% experiencing severe constipation. Constipation affects 6% of the Indian population, and it is linked to a number of comorbidities. The Gut Health Survey sheds light on the plight of these "silent patients," as well as the causes of chronic constipation and the issues that come with it. Abbott collaborated with IPSOS, a worldwide market research and consultancy business, to conduct a survey of 4,133 people in eight cities: Mumbai, Delhi, Kolkata, Hyderabad, Chennai, Patna, Ahmedabad, and Lucknow. The survey of eight cities found that metros (23 percent) have a higher percentage of constipation sufferers than non-metros (19%). With 28 % of sufferers, Kolkata leads the way, followed by Chennai with 26%.

The global bisacodyl market is segmented based on type and application. Based on the type, the market is segmented into high purity and low purity. Based on the application, the market is sub-segmented into constipation and Neurogenic bowel dysfunction. Chronic constipation can affect up to 20 % of the population and harms the quality of life and causes psychological stress. For instance, according to the National Center for Biotechnology Information, the annual health care costs are estimated at $ 821 million spent annually on over-the-counter laxatives and visit physicians. Therefore, due to the raising and prevailing growth of constipation and Neurogenic bowel dysfunction, there is a high usage of high purity and low purity bisacodyl drugs.

The major companies serving the global bisacodyl market include Cipla ltd., Dr.Reddy's Laboratories, GlaxoSmithKline plc, LMG Pharma, Sanofi S.A and others. The players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2021, Shilpa Medicare launched PRUCALSHIL, orally disintegrating strips of 1mg and 2 mg in India for the treatment of chronic constipation.

Research Methodology

The market study of the global bisacodyl market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Bisacodyl Market Research and Analysis by Type.

2. Global Bisacodyl Market Research and Analysis by Application

The Report Covers:

• Comprehensive Research Methodology of the global bisacodyl market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global bisacodyl market.
• Insights about market determinants that are stimulating the global bisacodyl market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.